V. , V. .. Vi-i-i-i, . Bibliographi, and . Bibliographi-bibliographie-e-e-e, Ce travail s'inscrit dans le cadre de la recherche de polymorphismes génétiques d'activité d'enzymes de la superfamille des CYP450 et de l'étude

K. Ahn, S. Ma, H. Tsai, S. Gee, and B. Hammock, An immunoassay for a urinary metabolite as a biomarker of human exposure to the pyrethroid insecticide permethrin, Analytical and Bioanalytical Chemistry, vol.695, issue.3, pp.713-722, 2006.
DOI : 10.1007/s00216-005-0220-5

D. Allorge and M. Loriot, La pharmacogénétique ou la promesse d'une médecine personnalisée : variations du métabolisme et du transport des médicaments, Ann Biol Clin, vol.63, pp.499-511, 2004.

M. Alonso-galicia, K. Maier, A. Greene, A. Cowley, . Jr et al., Role of 20-hydroxyeicosatetraenoic acid in the renal and vasoconstrictor actions of angiotensin II, American Journal of Physiology - Regulatory, Integrative and Comparative Physiology, vol.283, issue.1, pp.60-68, 2002.
DOI : 10.1152/ajpregu.00664.2001

A. Alving, P. Carson, F. Cl, and C. Ickes, Enzymatic deficiency in primaquine-sensitive erythrocytes, Science, vol.124, pp.484-485, 1956.

L. Becquemont, Clinical Relevance of Pharmacogenetics, Drug Metabolism Reviews, vol.35, issue.4, pp.277-285, 2003.
DOI : 10.1056/NEJMe020119

E. Belay, J. Bresee, R. Holman, A. Khan, A. Shahriari et al., Reye's Syndrome in the United States from 1981 through 1997, New England Journal of Medicine, vol.340, issue.18, pp.1377-1382, 1999.
DOI : 10.1056/NEJM199905063401801

D. Bell, N. Plant, C. Rider, N. L. Brown, S. Ateitalla et al., cDNAs, Biochemical Journal, vol.294, issue.1, pp.173-180, 1993.
DOI : 10.1042/bj2940173

A. Bellamine, Y. Wang, M. Waterman, J. Gainer, E. Dawson et al., Characterization of the CYP4A11 gene, a second CYP4A gene in humans, Archives of Biochemistry and Biophysics, vol.409, issue.1, pp.221-227, 2003.
DOI : 10.1016/S0003-9861(02)00545-3

K. Berge and K. Berg, No effect of insertion/ deletion polymorphism at the ACE locus on normal blood pressure level or variability, Clinical Genetics, vol.184, issue.4, pp.169-74, 1994.
DOI : 10.1111/j.1399-0004.1994.tb04017.x

S. Bergström, N. Daniel, and B. Samuelsson, The enzymatic formation of prostaglandin E2 from arachidonic acid prostaglandins and related factors 32, Biochimica et Biophysica Acta (BBA) - General Subjects, vol.90, issue.1, pp.207-210, 1964.
DOI : 10.1016/0304-4165(64)90145-X

S. Bergström and J. Sjövall, The Isolation of Prostaglandin E from Sheep Prostate Glands., Acta Chemica Scandinavica, vol.14, pp.1701-1705, 1960.
DOI : 10.3891/acta.chem.scand.14-1701

E. Beutler, Study of glucose-6-phosphate dehydrogenase: History and molecular biology, American Journal of Hematology, vol.7, issue.1, pp.53-58, 1993.
DOI : 10.1002/ajh.2830420111

A. Bonnardeaux, S. Nadaud, A. Charru, X. Jeunemaitre, P. Corvol et al., Lack of Evidence for Linkage of the Endothelial Cell Nitric Oxide Synthase Gene to Essential Hypertension, Circulation, vol.91, issue.1, pp.96-102, 1995.
DOI : 10.1161/01.CIR.91.1.96

G. Bories and P. G. Xénobiotiques, Pages 426-452. Editeurs : Riboli E, Decloïtre F, Collet-Ribbing C, 1996.

L. Bradford, CYP2D6 allele frequency in European Caucasians, Asians, Africans and their descendants, Pharmacogenomics, vol.3, issue.2, pp.229-243, 2002.
DOI : 10.1517/14622416.3.2.229

R. Bruce, L. Turnbull, J. Newman, and J. Pitts, Metabolism of brompheniramine, Journal of Medicinal Chemistry, vol.11, issue.5, pp.1031-1034, 1968.
DOI : 10.1021/jm00311a026

L. Campbell, H. Wilson, A. Samuel, and D. Gompertz, Interactions of m-xylene and aspirin metabolism in man., Occupational and Environmental Medicine, vol.45, issue.2, pp.127-132, 1988.
DOI : 10.1136/oem.45.2.127

M. Canivenc-lavier, M. Vernevaut, M. Totis, M. Siess, J. Magdalon et al., Comparative effects of flavonoids and model inducers on drug-metabolizing enzymes in rat liver, Toxicology, vol.114, issue.1, pp.19-27, 1996.
DOI : 10.1016/S0300-483X(96)03412-9

K. Cartharius, K. Frech, K. Grote, B. Klocke, M. Haltmeier et al., MatInspector and beyond: promoter analysis based on transcription factor binding sites, Bioinformatics, vol.21, issue.13, pp.2933-2942, 2005.
DOI : 10.1093/bioinformatics/bti473
URL : http://bioinformatics.oxfordjournals.org/cgi/content/short/21/13/2933

B. Cho, B. Park, L. Kim, H. Chung, and H. Shin, Highly polymorphic human CYP4A11 gene, Journal of Human Genetics, vol.3, issue.182, pp.259-263, 2005.
DOI : 10.1007/s10038-005-0245-9

S. Chuang, C. Helvig, M. Taimi, H. Ramshaw, A. Collop et al., CYP2U1, a Novel Human Thymus- and Brain-specific Cytochrome P450, Catalyzes ??- and (??-1)-Hydroxylation of Fatty Acids, Journal of Biological Chemistry, vol.279, issue.8, pp.6305-6314, 2004.
DOI : 10.1074/jbc.M311830200

X. Cui, D. Nelson, and H. Strobel, A Novel Human Cytochrome P450 4F Isoform (CYP4F11): cDNA Cloning, Expression, and Genomic Structural Characterization, Genomics, vol.68, issue.2, pp.161-166, 2000.
DOI : 10.1006/geno.2000.6276

C. Cullin and D. Pompon, Synthesis of functional mouse cytochromes P-450 P1 and chimeric P-450 P3-1 in the yeast Saccharomyces cerevisiae, Gene, vol.65, issue.2, pp.203-217, 1988.
DOI : 10.1016/0378-1119(88)90457-X

B. Daikh, R. Laethem, and D. Koop, Stereoselective epoxidation of arachidonic acid by cytochrome P-450s 2CAA and 2C2, J Pharmacol Exp Ther, vol.269, pp.1130-1135, 1994.

R. Deeley, C. Westlake, and S. Cole, Transmembrane Transport of Endo- and Xenobiotics by Mammalian ATP-Binding Cassette Multidrug Resistance Proteins, Physiological Reviews, vol.86, issue.3, pp.849-899, 2006.
DOI : 10.1152/physrev.00035.2005

V. Dessaignes, Nouvelles recherches sur l'acide hippurique, l'acide benzoique et le sucre de gelatine, Compte Rendu de l'Academie des Sciences, pp.1224-1227, 1845.

S. Diaz, M. Moreno, L. Dominguez, G. Suarez, and J. Blanco, Application of a Diphasic Dialysis Technique to the Extraction of Aflatoxins in Dairy Products, Journal of Dairy Science, vol.76, issue.7, pp.1845-1849, 1993.
DOI : 10.3168/jds.S0022-0302(93)77517-7

H. Ding, G. Cui, L. Zhang, Y. Xu, X. Bao et al., Association of common variants of CYP4A11 and CYP4F2 with stroke in the Han Chinese population, Pharmacogenetics and Genomics, vol.20, issue.3, pp.187-194, 2010.
DOI : 10.1097/FPC.0b013e328336eefe

J. Dorne, K. Walton, W. Slob, and A. Renwick, Human variability in polymorphic CYP2D6 metabolism: is the kinetic default uncertainty factor adequate?, Food and Chemical Toxicology, vol.40, issue.11, pp.1633-1656, 2002.
DOI : 10.1016/S0278-6915(02)00117-5

C. Eap, M. Bochud, R. Elston, P. Bovet, M. Maillard et al., CYP3A5 and ABCB1 Genes Influence Blood Pressure and Response to Treatment, and Their Effect Is Modified by Salt, Hypertension, vol.49, issue.5, pp.1007-1021, 2007.
DOI : 10.1161/HYPERTENSIONAHA.106.084236

R. Elbekai and A. El-kadi, Cytochrome P450 enzymes: Central players in cardiovascular health and disease, Pharmacology & Therapeutics, vol.112, issue.2, pp.564-587, 2006.
DOI : 10.1016/j.pharmthera.2005.05.011

B. Escalante, D. Sacerdoti, M. Davidian, M. Laniado-schwartzman, and J. Mcgiff, Chronic treatment with tin normalizes blood pressure in spontaneously hypertensive rats., Hypertension, vol.17, issue.6_Pt_1, pp.776-779, 1991.
DOI : 10.1161/01.HYP.17.6.776

W. Evans and M. Relling, Moving towards individualized medicine with pharmacogenomics, Nature, vol.287, issue.6990, pp.464-468, 2004.
DOI : 10.1038/nrg1229

W. Evans and M. Relling, Pharmacogenomics: Translating Functional Genomics into Rational Therapeutics, Science, vol.286, issue.5439, pp.487-491, 2000.
DOI : 10.1126/science.286.5439.487

C. Fava, M. Montagnana, P. Almgren, L. Rosberg, G. Lippi et al., The V433M Variant of the CYP4F2 Is Associated With Ischemic Stroke in Male Swedes Beyond Its Effect on Blood Pressure, Hypertension, vol.52, issue.2, pp.373-380, 2008.
DOI : 10.1161/HYPERTENSIONAHA.108.114199

S. Ferreira, S. Moncada, and J. Vane, Indomethacin and Aspirin abolish Prostaglandin Release from the Spleen, Nature New Biology, vol.231, issue.25, pp.237-239, 1971.
DOI : 10.1038/newbio231237a0

I. Fleming, Cytochrome P450 and Vascular Homeostasis, Circulation Research, vol.89, issue.9, pp.753-62, 2001.
DOI : 10.1161/hh2101.099268

Z. Fu, T. Nakayama, N. Sato, Y. Izumi, Y. Kasamaki et al., Haplotype-based case study of human CYP4A11 gene and cerebral infarction in Japanese subject, Endocrine, vol.23, issue.2, pp.215-222, 2008.
DOI : 10.1007/s12020-008-9078-6

Z. Fu, T. Nakayama, N. Sato, Y. Izumi, Y. Kasamaki et al., A haplotype of the CYP4A11 gene associated with essential hypertension in Japanese men, Journal of Hypertension, vol.26, issue.3, pp.453-461, 2008.
DOI : 10.1097/HJH.0b013e3282f2f10c

J. Gainer, A. Bellamine, E. Dawson, K. Womble, S. Grant et al., Functional Variant of CYP4A11 20-Hydroxyeicosatetraenoic Acid Synthase Is Associated With Essential Hypertension, Circulation, vol.111, issue.1, pp.63-69, 2005.
DOI : 10.1161/01.CIR.0000151309.82473.59

J. Gainer, M. Lipkowitz, C. Yu, M. Waterman, E. Dawson et al., Association of a CYP4A11 Variant and Blood Pressure in Black Men, Journal of the American Society of Nephrology, vol.19, issue.8, pp.1606-1612, 2008.
DOI : 10.1681/ASN.2008010063

D. Gebremedhin, A. Lange, J. Narayanan, M. Aebly, E. Jacobs et al., current, The Journal of Physiology, vol.270, issue.3, pp.771-781, 1998.
DOI : 10.1111/j.1469-7793.1998.771bs.x

T. Gerloff, Impact of genetic polymorphisms in transmembrane carrier-systems on drug and xenobiotic distribution, Naunyn-Schmiedeberg's Archives of Pharmacology, vol.369, issue.2, p.268, 2004.
DOI : 10.1007/s00210-003-0856-7

G. Gibson, Comparative aspects of the mammalian cytochrome P450 IV gene family, Xenobiotica, vol.80, issue.10, pp.1123-1148, 1989.
DOI : 10.1038/283397a0

D. Gietz, S. Jean, A. Woods, R. Schiestl, and R. , Improved method for high efficiency transformation of intact yeast cells, Nucleic Acids Research, vol.20, issue.6, p.1425, 1992.
DOI : 10.1093/nar/20.6.1425

R. Goldberg, D. Sargent, R. Morton, C. Frichs, R. Ramamathan et al., A Randomized Controlled Trial of Fluorouracil Plus Leucovorin, Irinotecan, and Oxaliplatin Combinations in Patients With Previously Untreated Metastatic Colorectal Cancer, Journal of Clinical Oncology, vol.22, issue.1, pp.23-30, 2004.
DOI : 10.1200/JCO.2004.09.046

F. Gonzalez and K. Korzekwa, Cytochromes P450 Expression Systems, Annual Review of Pharmacology and Toxicology, vol.35, issue.1, pp.369-390, 1995.
DOI : 10.1146/annurev.pa.35.040195.002101

F. Gonzalez, R. Skoda, S. Kimura, M. Umeno, U. Zanger et al., Characterization of the common genetic defect in humans deficient in debrisoquine metabolism, Nature, vol.331, issue.6155, pp.442-446, 1988.
DOI : 10.1038/331442a0

S. Gradelet, L. Bon, A. Berges, R. Suschetet, M. Astorg et al., Dietary carotenoids inhibit aflatoxin B1-induced liver preneoplastic foci and DNA damage in the rat: role of the modulation of aflatoxin B1 metabolism, Carcinogenesis, vol.19, issue.3, pp.403-411, 1997.
DOI : 10.1093/carcin/19.3.403

D. Grant, Detoxification pathways in the liver, Journal of Inherited Metabolic Disease, vol.43, issue.4, pp.421-430, 1991.
DOI : 10.1007/BF01797915

M. Hamberg and B. Samuelsson, The mecanism of the biosynthesis of prostaglandins E1 and F1, J Biol Chem, vol.242, pp.5336-5343, 1967.

D. Harder, W. Campbell, and R. Roman, Role of Cytochrome P-450 Enzymes and Metabolites of Arachidonic Acid in the Control of Vascular Tone, Journal of Vascular Research, vol.32, issue.2, pp.79-92, 1995.
DOI : 10.1159/000159080

J. Hardwick, B. Song, E. Huberman, and F. Gonzalez, Isolation, complementary DNA sequence, and regulation of rat hepatic lauric acid omegahydroxylase (cytochrome P-450LA omega) Identification of a new cytochrome P-450 gene family, J Biol Chem, vol.262, pp.801-810, 1987.

K. Hayashi and D. Yandell, How sensitive is PCR-SSCP?, Human Mutation, vol.211, issue.5, pp.338-346, 1993.
DOI : 10.1002/humu.1380020503

M. Hediger, M. Romero, J. Peng, A. Rolfs, H. Takanaga et al., The ABCs of solute carriers: physiological, pathological and therapeutic implications of human membrane transport proteins, Pfl???gers Archiv European Journal of Physiology, vol.447, issue.5, pp.465-473, 2004.
DOI : 10.1007/s00424-003-1192-y

Y. Heng, C. Kuo, P. Jones, R. Savory, R. Schulz et al., A novel murine P-450 gene, Cyp4a14, is part of a cluster of Cyp4a and Cyp4b, but not of CYP4F, genes in mouse and humans, Biochemical Journal, vol.325, issue.3, pp.741-749, 1997.
DOI : 10.1042/bj3250741

M. Hermann, J. Hellermann, K. Quitzau, M. Hoffmann, T. Gasser et al., CYP4A11 polymorphism correlates with coronary endothelial dysfunction in patients with coronary artery disease???The ENCORE Trials, Atherosclerosis, vol.207, issue.2, pp.476-479, 2009.
DOI : 10.1016/j.atherosclerosis.2009.06.009

M. Hiratsuka, H. Nozawa, Y. Katsumoto, T. Moteki, T. Sasaki et al., Genetic polymorphisms and haplotype structures of the CYP4A22 gene in a Japanese population, Mutation Research/Fundamental and Molecular Mechanisms of Mutagenesis, vol.599, issue.1-2, pp.98-104, 2006.
DOI : 10.1016/j.mrfmmm.2006.02.008

V. Holla, F. Adas, J. Imig, X. Zhao, E. Price et al., Alterations in the regulation of androgen-sensitive Cyp 4a monooxygenases cause hypertension, Proceedings of the National Academy of Sciences, vol.98, issue.9, pp.5211-5216, 2001.
DOI : 10.1073/pnas.081627898

H. Hughes, J. Biehl, A. Jones, and L. Schmidt, Metabolism of isoniazid in man as related to the occurrence of peripheral neuritis, Am Rev Tuberc, vol.70, pp.266-273, 1954.

S. Imaoka, T. Hiroi, Y. Tamura, H. Yamazaki, T. Shimada et al., Mutagenic Activation of 3-Methoxy-4-aminoazobenzene by Mouse Renal Cytochrome-P450 CYP4B1: Cloning and Characterization of Mouse CYP4B1, Archives of Biochemistry and Biophysics, vol.321, issue.1, pp.255-262, 1995.
DOI : 10.1006/abbi.1995.1393

M. Ingelman-sundberg, Genetic Polymorphism of Drug Metabolizing Enzymes. Implications for Toxicity of Drugs and Other Xenobiotics, Arch Toxicol, vol.19, pp.3-13, 1997.
DOI : 10.1007/978-3-642-60682-3_1

O. Ito, M. Alonso-galicia, K. Hopp, and R. Roman, Localization of cytochrome P- 450 4A isoforms along the rat nephron, Am J Physiol, vol.274, pp.395-404, 1998.

J. Iwai, Y. Kanayama, N. Negoro, M. Okamura, and T. Takeda, GENE EXPRESSION OF ENDOTHELIN RECEPTORS IN AORTIC CELLS FROM CYCLOSPORINE-INDUCED HYPERTENSIVE RATS, Clinical and Experimental Pharmacology and Physiology, vol.90, issue.6-7, pp.404-409, 1995.
DOI : 10.1038/332411a0

W. Ji, J. Foo, O. Roak, B. Zhao, H. Larson et al., Rare independent mutations in renal salt handling genes contribute to blood pressure variation, Nature Genetics, vol.96, issue.5, pp.592-601, 2008.
DOI : 10.1093/ndt/16.4.691

I. Johansson, M. Oscarson, Q. Yue, L. Bertilsson, F. Sjoqvist et al., Genetic analysis of the Chinese cytochrome P450D locus: characterization of variant CYP2D6 genes present in subjects with diminished capacity for debrisoquine hydroxylation, Mol Pharmacol, vol.46, pp.452-459, 1994.

H. Kawashima, E. Kusunose, Y. Kikuta, H. Kinoshita, S. Tanaka et al., Purification and cDNA Cloning of Human Liver CYP4A Fatty Acid ??-Hydroxylase, The Journal of Biochemistry, vol.116, issue.1, pp.74-80, 1994.
DOI : 10.1093/oxfordjournals.jbchem.a124506

H. Kawashima, E. Kusunose, I. Kubota, M. Maekawa, and M. Kusunose, Purification and NH2-terminal amino acid sequences of human and rat kidney fatty acid ??-hydroxylases, Biochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism, vol.1123, issue.2, pp.156-162, 1992.
DOI : 10.1016/0005-2760(92)90106-6

P. Kearney, M. Whelton, K. Reynolds, P. Muntner, P. Whelton et al., Global burden of hypertension: analysis of worldwide data, The Lancet, vol.365, issue.9455, pp.217-223, 2005.
DOI : 10.1016/S0140-6736(05)70151-3

M. Kelley and D. Vessey, Characterization of the acyl-CoA: Amino acid N-acyltransferases from primate liver mitochondria, Journal of Biochemical Toxicology, vol.23, issue.3, pp.153-158, 1994.
DOI : 10.1002/jbt.2570090307

Y. Kikuta, M. Kato, Y. Yamashita, Y. Miyauchi, K. Tanaka et al., ) Gene: Molecular Cloning and Chromosomal Localization, DNA and Cell Biology, vol.17, issue.3, pp.221-230, 1998.
DOI : 10.1089/dna.1998.17.221

R. Kim, Transporters and xenobiotic disposition, Toxicology, vol.181, issue.182, pp.291-297, 2002.
DOI : 10.1016/S0300-483X(02)00296-2

S. Kimura, N. Hanioka, E. Matsunaga, and F. Gonzalez, Genes, Unique Exon Organization, and Identification of a Conserved 19-bp Upstream Element, DNA, vol.8, issue.7, pp.503-516, 1989.
DOI : 10.1089/dna.1.1989.8.503

J. Kirchheiner, K. Brosen, M. Dahl, L. Gram, S. Kasper et al., CYP2D6 and CYP2C19 genotype-based dose recommendations for antidepressants: a first step towards subpopulation-specific dosages, Acta Psychiatrica Scandinavica, vol.96, issue.3, pp.173-192, 2001.
DOI : 10.1001/jama.279.15.1200

D. Kroetz, P. Yook, P. Costet, P. Bianchi, and T. Pineau, Peroxisome Proliferator-activated Receptor ?? Controls the Hepatic CYP4A Induction Adaptive Response to Starvation and Diabetes, Journal of Biological Chemistry, vol.273, issue.47, pp.31581-31589, 1998.
DOI : 10.1074/jbc.273.47.31581

D. Kroetz and D. Zeldin, Cytochrome P450 pathways of arachidonic acid metabolism, Current Opinion in Lipidology, vol.13, issue.3, pp.273-283, 2002.
DOI : 10.1097/00041433-200206000-00007

M. Kunert, R. Roman, M. Alonso-galicia, J. Falck, and J. Lombard, Cytochrome P-450 omega-hydroxylase: a potential O(2) sensor in rat arterioles and skeletal muscle cells, Am J Physiol Heart Circ Physiol, vol.280, pp.1840-1845, 2001.

T. Kupiec, R. V. Vu, and N. , Pharmacogenomics for the Forensic Toxicologist, Journal of Analytical Toxicology, vol.30, issue.2, pp.65-72, 2006.
DOI : 10.1093/jat/30.2.65

R. Laethem, M. Balazy, and D. Koop, Epoxidation of C18 unsaturated fatty acids by cytochromes P4502C2 and P4502CAA, Drug Metab Dispos, vol.24, pp.664-668, 1996.

C. Laffer, J. Gainer, M. Waterman, J. Capdevila, M. Laniado-schwartzman et al., The T8590C Polymorphism of CYP4A11 and 20-Hydroxyeicosatetraenoic Acid in Essential Hypertension, Hypertension, vol.51, issue.3, pp.767-772, 2008.
DOI : 10.1161/HYPERTENSIONAHA.107.102921

J. Lasker, W. Chen, I. Wolf, B. Bloswick, P. Wilson et al., Formation of 20-Hydroxyeicosatetraenoic Acid, a Vasoactive and Natriuretic Eicosanoid, in Human Kidney: ROLE OF CYP4F2 AND CYP4A11, Journal of Biological Chemistry, vol.275, issue.6, pp.4118-4126, 2000.
DOI : 10.1074/jbc.275.6.4118

C. Lawes, S. Vander-hoorn, and A. Rodgers, Global burden of blood-pressure-related disease, 2001, The Lancet, vol.371, issue.9623, pp.1513-1518, 2001.
DOI : 10.1016/S0140-6736(08)60655-8

J. Lazarou, B. Pomeranz, and P. Corey, Incidence of Adverse Drug Reactions in Hospitalized Patients, JAMA, vol.279, issue.15, pp.1200-1205, 1998.
DOI : 10.1001/jama.279.15.1200

G. Levy, Pharmacokinetics of Salicylate Elimination in Man, Journal of Pharmaceutical Sciences, vol.54, issue.7, pp.959-967, 1965.
DOI : 10.1002/jps.2600540703

G. Levy, Salicylurate Formation???Demonstration of Michaelis-menten kinetics in Man, Journal of Pharmaceutical Sciences, vol.54, issue.3, p.496, 1965.
DOI : 10.1002/jps.2600540348

J. Li, D. Norwood, L. Mao, and H. Schulz, Mitochondrial metabolism of valproic acid, Biochemistry, vol.30, pp.388-394, 1991.

R. Lifton, Molecular Genetics of Human Blood Pressure Variation, Science, vol.272, issue.5262, pp.676-680, 1996.
DOI : 10.1126/science.272.5262.676

H. Liu, Y. Zhao, W. Gong, J. Shi, L. Fu et al., Correlation analysis and identification of G421C in regulatory region of CYP4F2 gene with essential hypertension], Zhongguo Yi Xue Ke Xue Yuan Xue Bao, vol.28, pp.143-147, 2006.

C. Lorentz, E. Wieben, A. Tefferi, D. Whiteman, and G. Dewald, Primer on Medical Genomics Part I: History of Genetics and Sequencing of the Human Genome, Mayo Clinic Proceedings, vol.77, issue.8, p.775, 2002.
DOI : 10.4065/77.8.773

L. Mancinelli, M. Cronin, and W. Sadée, Pharmacogenomics: The promise of personalized medicine, AAPS PharmSci, vol.2, issue.1, pp.2-3, 2000.
DOI : 10.1208/ps020104

M. Manson, H. Ball, M. Barrett, H. Clark, D. Judah et al., Mechanism of action of dietary chemoprotective agents in rat liver: induction of phase I and II drug metabolizing enzymes and aflatoxin B1 metabolism, Carcinogenesis, vol.18, issue.9, pp.1729-1738, 1997.
DOI : 10.1093/carcin/18.9.1729

S. Marsh, M. Leod, and H. , Pharmacogenetics of irinotecan toxicity, Pharmacogenomics, vol.5, issue.7, pp.835-843, 2004.
DOI : 10.1517/14622416.5.7.835

Y. Mawal and I. Qureshi, Purification to Homogeneity of Mitochondrial Acyl CoA: Glycine N-Acyltransferase from Human Liver, Biochemical and Biophysical Research Communications, vol.205, issue.2, pp.1373-1379, 1994.
DOI : 10.1006/bbrc.1994.2817

B. Mayer, W. Lieb, A. Götz, I. König, Z. Aherrahrou et al., Association of the T8590C Polymorphism of CYP4A11 With Hypertension in the MONICA Augsburg Echocardiographic Substudy, Hypertension, vol.46, issue.4, pp.766-771, 2005.
DOI : 10.1161/01.HYP.0000182658.04299.15

B. Mayer, W. Lieb, A. Götz, I. König, L. Kauschen et al., Association of a functional polymorphism in the CYP4A11 gene with systolic blood pressure in survivors of myocardial infarction, Journal of Hypertension, vol.24, issue.10, pp.1965-1970, 2006.
DOI : 10.1097/01.hjh.0000244944.34546.8e

J. Mcgiff and J. Quilley, 20-HETE and the kidney: resolution of old problems and new beginnings, Am J Physiol, vol.277, pp.607-623, 1999.

R. Mclellan, M. Oscarson, A. Alexandrie, J. Seidegård, D. Evans et al., Characterization of a human glutathione Stransferase mu cluster containing a duplicated GSTM1 gene that causes ultrarapid enzyme activity, Mol Pharmacol, vol.52, pp.958-965, 1997.

R. Mclellan, M. Oscarson, J. Seidegård, and D. Evans, Frequent occurrence of CYP2D6 gene duplication in Saudi Arabians, Pharmacogenetics, vol.7, issue.3, pp.187-191, 1997.
DOI : 10.1097/00008571-199706000-00003

W. Meuldermans, J. Hendrickx, W. Lauwers, R. Hurkmans, E. Swysen et al., Excretion and biotransformation of astemizole in rats, guinea-pigs, dogs, and man, Drug Development Research, vol.20, issue.1-4, pp.37-351, 1986.
DOI : 10.1002/ddr.430080106

V. Michaud and J. Turgeon, L'importance clinique des interactions médicamenteuses reliées aux isoenzymes du cytochrome P450: de la fiction à la réalité, Pharmactuel, vol.36, pp.88-96, 2003.

N. Miyata and R. Roman, Role of 20-hydroxyeicosatetraenoic acid (20-HETE) in vascular system, Journal of Smooth Muscle Research, vol.41, issue.4, pp.175-193, 2005.
DOI : 10.1540/jsmr.41.175

J. Mongeau, Heredity and blood pressure in humans: an overview, Pediatric Nephrology, vol.36, issue.A, pp.69-75, 1987.
DOI : 10.1007/BF00866887

C. Mounier-vehier, G. Amah, and J. Covillard, Prise en charge de l'HTA essentielle et du niveau de risque cardiovasculaire : Enquête nationale PHENOMEN, Arch Mal Coeur Vaiss, vol.95, pp.667-672, 2002.

D. Murdoch and G. Plosker, Triflusal, Drugs, vol.50, issue.8, pp.671-692, 2006.
DOI : 10.2165/00003495-200666050-00009

D. Nebert and A. Menon, Pharmacogenomics, ethnicity, and susceptibility genes, The Pharmacogenomics Journal, vol.96, issue.1, pp.19-22, 2001.
DOI : 10.1038/sj.tpj.6500002

D. Nebert and D. Russell, Clinical importance of the cytochromes P450, The Lancet, vol.360, issue.9340, pp.1155-1162, 2002.
DOI : 10.1016/S0140-6736(02)11203-7

D. Nelson, L. Koymans, T. Kamataki, J. Stegeman, R. Feyereisen et al., P450 superfamily: update on new sequences, gene mapping, accession numbers and nomenclature, Pharmacogenetics, vol.6, issue.1, pp.1-42, 1996.
DOI : 10.1097/00008571-199602000-00002

D. Nelson, L. Koymans, T. Kamataki, J. Stegeman, R. Feyereisen et al., P450 superfamily: update on new sequences, gene mapping, accession numbers and nomenclature, Pharmacogenetics, vol.6, issue.1, pp.1-42, 1996.
DOI : 10.1097/00008571-199602000-00002

D. Nelson, D. Zeldin, S. Hoffman, L. Maltais, H. Wain et al., Comparison of cytochrome P450 (CYP) genes from the mouse and human genomes, including nomenclature recommendations for genes, pseudogenes and alternative-splice variants, Pharmacogenetics, vol.14, issue.1, pp.1-18, 2004.
DOI : 10.1097/00008571-200401000-00001

X. Nguyen, M. Wang, K. Reddy, J. Falck, and M. Schwartzman, Kinetic profile of the rat CYP4A isoforms: arachidonic acid metabolism and isoformspecific inhibitors, Am J Physiol, vol.276, pp.246-253, 1999.

B. Nutley, P. Farmer, and J. Caldwell, Metabolism of trans-cinnamic acid in the rat and the mouse and its variation with dose, Food and Chemical Toxicology, vol.32, issue.10, pp.877-886, 1994.
DOI : 10.1016/0278-6915(94)90085-X

K. Oestreicher, J. Desmeules, V. Piguet, and P. Dayer, Interactions médicamenteuses: le rôle des cytochromes P450 (CYP), Med Hyg, vol.57, pp.793-800, 1999.

E. Oliw, Oxygenation of polyunsaturated fatty acids by cytochrome P450 monooxygenates, Progress in Lipid Research, vol.33, issue.3, pp.329-354, 1994.
DOI : 10.1016/0163-7827(94)90029-9

K. Omata, N. Abraham, and M. Schwartzman, Renal cytochrome P-450- arachidonic acid metabolism: localization and hormonal regulation in SHR, Am J Physiol, vol.262, pp.591-599, 1992.

T. Omura and R. Sato, The carbon monoxide-binding pigment of liver microsomes. Evidence for its hemoprotein nature, J Biol Chem, vol.239, pp.2370-2378, 1964.

M. Orita, H. Iwahana, H. Kanazawa, K. Hayashi, and T. Sekiya, Detection of polymorphisms of human DNA by gel electrophoresis as single-strand conformation polymorphisms., Proceedings of the National Academy of Sciences, vol.86, issue.8, pp.2766-2770, 1989.
DOI : 10.1073/pnas.86.8.2766

M. Oscarson, Genetic polymorphisms in the cytochrome P450 2A6 (CYP2A6) gene: implications for interindividual differences in nicotine metabolism, Drug Metab Dispos, vol.29, pp.91-95, 2001.

M. Oscarson, Pharmacogenetics of Drug Metabolising Enzymes: Importance for Personalised Medicine, Clinical Chemistry and Laboratory Medicine, vol.41, issue.4, pp.573-580, 2003.
DOI : 10.1515/CCLM.2003.087

A. Parkinson and B. Ogilvie, Casarett and Doull's toxicology: the basic science of poisons. Chapter 6, Editeur Klaassen CD, pp.113-186, 1996.

M. Peyronneau, J. Renaud, G. Truan, P. Urban, D. Pompon et al., Optimization of yeast-expressed human liver cytochrome P450 3A4 catalytic activities by coexpressing NADPH-cytochrome P450 reductase and cytochrome b5, European Journal of Biochemistry, vol.35, issue.1, pp.109-116, 1992.
DOI : 10.1016/0300-9084(90)90070-W

D. Pompon, B. Louerat, A. Bronine, and P. Urban, [6] Yeast expression of animal and plant P450s in optimized redox environments, Methods Enzymol, vol.272, pp.51-64, 1996.
DOI : 10.1016/S0076-6879(96)72008-6

D. Pompon, cDNA cloning and functional expression in yeast Saccharomyces cerevisiae of beta-naphthoflavone-induced rabbit liver P-450 LM4 and LM6, European Journal of Biochemistry, vol.6, issue.2, pp.285-293, 1988.
DOI : 10.1016/0378-1119(88)90457-X

P. Powell, I. Wolf, J. R. Lasker, and J. , Metabolism of arachidonic acid to 20- hydroxy-5 14-eicosatetraenoic acid by P450 enzymes in human liver: involvement of CYP4F2 and CYP4A11, J Pharmacol Exp Ther, vol.811, issue.285, pp.1327-1336, 1998.

W. Qu, J. Bradbury, C. Tsao, R. Maronpot, G. Harry et al., Cytochrome P450 CYP2J9, a New Mouse Arachidonic Acid omega -1 Hydroxylase Predominantly Expressed in Brain, Journal of Biological Chemistry, vol.276, issue.27, pp.25467-25479, 2001.
DOI : 10.1074/jbc.M100545200

M. Ravnik-glavac, D. Glavac, and M. Dean, Sensitivity of single-strand conformation polymorphism and heteroduplex method for mutation detection in the cystic fibrosis gene, Human Molecular Genetics, vol.3, issue.5, pp.801-807, 1994.
DOI : 10.1093/hmg/3.5.801

S. Rendic, Summary of information on human CYP enzymes: human P450 metabolism data, Drug Metabolism Reviews, vol.131, issue.2, pp.255-259, 2002.
DOI : 10.1211/0022357011775479

S. Rendic, Summary of information on human CYP enzymes: human P450 metabolism data, Drug Metabolism Reviews, vol.131, issue.2, pp.83-448, 2002.
DOI : 10.1211/0022357011775479

L. Reuss, Basolateral KCl co-transport in a NaCl-absorbing epithelium, Nature, vol.396, issue.5936, pp.723-729, 1983.
DOI : 10.1038/305723a0

A. Rifkind, C. Lee, T. Chang, and D. Waxman, Arachidonic acid metabolism by human cytochrome P450s 2C8, 2C9, 2E1, and 1A2: Regioselective oxygenation and evidence for a role for CYP2C enzymes in arachidonic acid epoxygenation in human liver microsomes, Archives of Biochemistry and Biophysics, vol.320, issue.2, pp.380-389, 1995.
DOI : 10.1016/0003-9861(95)90023-3

B. Rigat, C. Hubert, F. Alhenc-gelas, F. Cambien, P. Corvol et al., An insertion/deletion polymorphism in the angiotensin I-converting enzyme gene accounting for half the variance of serum enzyme levels., Journal of Clinical Investigation, vol.86, issue.4, pp.1343-1349, 1990.
DOI : 10.1172/JCI114844

R. Roman, K. Maier, C. Sun, D. Harder, and M. Alonso-galicia, Renal And Cardiovascular Actions Of 20-Hydroxyeicosatetraenoic Acid And Epoxyeicosatrienoic Acids, Clinical and Experimental Pharmacology and Physiology, vol.275, issue.11, pp.855-865, 2000.
DOI : 10.1016/S0014-2999(99)00470-7

M. Romkes, M. Faletto, J. Blaisdell, J. Raucy, and J. Goldstein, Cloning and expression of complementary DNAs for multiple members of the human cytochrome P450IIC subfamily, Biochemistry, vol.30, issue.13, pp.3247-3255, 1991.
DOI : 10.1021/bi00227a012

D. Sacerdoti, N. Abraham, J. Mcgiff, and M. Schwartzman, Renal cytochrome P-450-dependent metabolism of arachidonic acid in spontaneously hypertensive rats, Biochemical Pharmacology, vol.37, issue.3, pp.521-517, 1988.
DOI : 10.1016/0006-2952(88)90223-7

D. Sacerdoti, B. Escalante, N. Abraham, J. Mcgiff, R. Levere et al., Treatment with tin prevents the development of hypertension in spontaneously hypertensive rats, Science, vol.243, issue.4889, pp.388-390, 1989.
DOI : 10.1126/science.2492116

D. Schachter and J. Taggart, Benzoyl coenzyme A and hippurate synthesis, J Biol Chem, vol.203, pp.925-934, 1953.

H. Schunkert, H. Hense, S. Holmer, M. Stender, S. Perz et al., Association between a Deletion Polymorphism of the Angiotensin-Converting-Enzyme Gene and Left Ventricular Hypertrophy, New England Journal of Medicine, vol.330, issue.23, pp.1634-1642, 1994.
DOI : 10.1056/NEJM199406093302302

V. Sheffield, J. Beck, A. Kwitek, D. Sandstrom, and E. Stone, The Sensitivity of Single-Strand Conformation Polymorphism Analysis for the Detection of Single Base Substitutions, Genomics, vol.16, issue.2, pp.325-332, 1993.
DOI : 10.1006/geno.1993.1193

P. Shih, O. Connor, and D. , Hereditary Determinants of Human Hypertension: Strategies in the Setting of Genetic Complexity, Hypertension, vol.51, issue.6, pp.1456-1464, 2008.
DOI : 10.1161/HYPERTENSIONAHA.107.090480

A. Simpson, The cytochrome P450 4 (CYP4) family, General Pharmacology: The Vascular System, vol.28, issue.3, pp.351-359, 1997.
DOI : 10.1016/S0306-3623(96)00246-7

J. Smith and A. Willis, Aspirin Selectively Inhibits Prostaglandin Production in Human Platelets, Nature New Biology, vol.231, issue.25, pp.235-237, 1971.
DOI : 10.1038/newbio231235a0

P. Smith, R. Krohn, G. Hermanson, A. Mallia, F. Gartner et al., Measurement of protein using bicinchoninic acid, Analytical Biochemistry, vol.150, issue.1, pp.76-85, 1985.
DOI : 10.1016/0003-2697(85)90442-7

K. Sugimoto, H. Akasaka, T. Katsuya, K. Node, T. Fujisawa et al., A Polymorphism Regulates CYP4A11 Transcriptional Activity and Is Associated With Hypertension in a Japanese Population, Hypertension, vol.52, issue.6, pp.1142-1148, 2008.
DOI : 10.1161/HYPERTENSIONAHA.108.114082

O. Suh, S. Kim, and M. Lee, Pharmacokinetics and pharmacodynamics of azosemide, Biopharmaceutics & Drug Disposition, vol.25, issue.7, pp.275-297, 2003.
DOI : 10.1002/bdd.365

D. Sweet, Organic anion transporter (Slc22a) family members as mediators of toxicity, Toxicology and Applied Pharmacology, vol.204, issue.3, pp.198-215, 2005.
DOI : 10.1016/j.taap.2004.10.016

V. Tamasi, L. Vereczkey, A. Falus, and K. Monostory, Some aspects of interindividual variations in the metabolism of xenobiotics, Inflammation Research, vol.52, issue.8, pp.322-333, 2000.
DOI : 10.1007/s00011-003-1186-4

M. Tobin, M. Tomaszewski, P. Braund, C. Hajat, S. Raleigh et al., Common Variants in Genes Underlying Monogenic Hypertension and Hypotension and Blood Pressure in the General Population, Hypertension, vol.51, issue.6, pp.1658-64, 2008.
DOI : 10.1161/HYPERTENSIONAHA.108.112664

V. Ullrich, M. Zou, and M. Bachschmid, New physiological and pathophysiological aspects on the thromboxane A2???prostacyclin regulatory system, Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids, vol.1532, issue.1-2, pp.1-14, 2001.
DOI : 10.1016/S1388-1981(01)00126-3

P. Urban, C. Mignotte, M. Kazmaier, F. Delorme, and D. Pompon, Cloning, Yeast Expression, and Characterization of the Coupling of Two Distantly Related Arabidopsis thalianaNADPH-Cytochrome P450 Reductases with P450 CYP73A5, Journal of Biological Chemistry, vol.272, issue.31, pp.19176-19186, 1997.
DOI : 10.1074/jbc.272.31.19176

A. Ure, On Gouty Concretions, with a New Method of Treatment, Journal of the Royal Society of Medicine, vol.24, issue.1, pp.30-35, 1841.
DOI : 10.1177/095952874102400105

J. Vane, Inhibition of Prostaglandin Synthesis as a Mechanism of Action for Aspirin-like Drugs, Nature New Biology, vol.231, issue.25, pp.232-235, 1971.
DOI : 10.1038/newbio231232a0

F. Vogel, Moderne probleme der Humanenetik, J Ergeb Inn Med Kinderheilkd, vol.12, pp.52-125, 1959.

V. Euler and U. , On the specific vaso-dilating and plain muscle stimulating substances from accessory genital glands in man and certain animals (prostaglandin and vesiglandin), The Journal of Physiology, vol.88, issue.2, pp.213-234, 1937.
DOI : 10.1113/jphysiol.1936.sp003433

M. Wang, F. Zhang, M. J. Zand, B. Nasjletti, A. Laniado-schwartzman et al., CYP4A1 antisense oligonucleotide reduces mesenteric vascular reactivity and blood pressure in SHR, Am J Physiol Regul Integr Comp Physiol, vol.280, pp.255-261, 2001.

N. Ward, I. Tsai, A. Barden, F. Van-bockxmeer, I. Puddey et al., A Single Nucleotide Polymorphism in the CYP4F2 but not CYP4A11 Gene Is Associated With Increased 20-HETE Excretion and Blood Pressure, Hypertension, vol.51, issue.5, pp.1393-1398, 2008.
DOI : 10.1161/HYPERTENSIONAHA.107.104463

L. Webster, U. Siddiqui, S. Lucas, J. Strong, and J. Mieyal, Identification of separate acyl- CoA:glycine and acyl-CoA:L-glutamine Nacyltransferase activities in mitochondrial fractions from liver of rhesus monkey and man, J Biol Chem, vol.251, pp.3352-3358, 1976.

W. Xiao and P. Oefner, Denaturing high-performance liquid chromatography: A review, Human Mutation, vol.18, issue.6, pp.439-474, 2001.
DOI : 10.1002/humu.1130

J. Zhang and J. Cashman, QUANTITATIVE ANALYSIS OF FMO GENE mRNA LEVELS IN HUMAN TISSUES, Drug Metabolism and Disposition, vol.34, issue.1, pp.19-26, 2006.
DOI : 10.1124/dmd.105.006171